toripalimab
junshi biosciences,coherus
['neotorch', 'toripalimab', 'lcsm,(-blcsm)']
#asco23 #neotorch: perioperative toripalimab/chemo vs chemo in resectable #lcsm toripalimab arm showed significant improvement in efs . mpr and pcr rates also observed with toripalimab safety profile was ?manageable, despite more iraes . 
Fellow @MayoHemeOnc | @UConnIM| @UTexasSPH| @MDAndersonNews|@COVID19nCCC| #SoMeEditor @JCOCCI_ASCO| Co-Host @HemOncFellows @LungCancerRX https://t.co/dsiuV460lQ